Literature DB >> 16780873

A cytotoxic ribonuclease variant with a discontinuous nuclear localization signal constituted by basic residues scattered over three areas of the molecule.

M Rodríguez1, A Benito, P Tubert, J Castro, M Ribó, B Beaumelle, M Vilanova.   

Abstract

Nuclear import of proteins is determined by specific signals that allow them to bind to receptors that mediate their energy-dependent transport through the nuclear pore. These signals are termed nuclear localization signals and do not constitute a specific consensus sequence. Among them, the most characterized correspond to monopartite and bipartite nuclear localization signals, which interact with the importin alpha/beta heterodimer. We previously described a cytotoxic variant of human pancreatic-ribonuclease that is actively transported into the nucleus. Here, we show that this protein interacts with importin alpha through different basic residues, including Lys1 and the arginine clusters 31-33 and 89-91. Although these residues are scattered along the sequence, they are close in the three-dimensional structure of the protein and their topological disposition strongly resembles that of a classical bipartite nuclear localization signal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780873     DOI: 10.1016/j.jmb.2006.05.048

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  The nuclear transport capacity of a human-pancreatic ribonuclease variant is critical for its cytotoxicity.

Authors:  Pere Tubert; Montserrat Rodríguez; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Invest New Drugs       Date:  2010-03-30       Impact factor: 3.850

2.  A cytotoxic ribonuclease reduces the expression level of P-glycoprotein in multidrug-resistant cell lines.

Authors:  Jessica Castro; Marc Ribó; Teresa Puig; Ramon Colomer; Maria Vilanova; Antoni Benito
Journal:  Invest New Drugs       Date:  2011-02-01       Impact factor: 3.850

Review 3.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

4.  Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platform.

Authors:  Thomas Schirrmann; André Frenzel; Lars Linden; Beatrix Stelte-Ludwig; Jörg Willuda; Axel Harrenga; Stefan Dübel; Beate Müller-Tiemann; Mark Trautwein
Journal:  MAbs       Date:  2014-01-15       Impact factor: 5.857

5.  A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation.

Authors:  Jessica Castro; Marc Ribó; Susanna Navarro; Maria Victòria Nogués; Maria Vilanova; Antoni Benito
Journal:  BMC Cancer       Date:  2011-01-11       Impact factor: 4.430

6.  A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2016-04-05

Review 7.  Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents.

Authors:  Jessica Castro; Marc Ribó; Maria Vilanova; Antoni Benito
Journal:  Pharmaceutics       Date:  2021-01-09       Impact factor: 6.321

8.  The Selectivity for Tumor Cells of Nuclear-Directed Cytotoxic RNases Is Mediated by the Nuclear/Cytoplasmic Distribution of p27KIP1.

Authors:  Glòria García-Galindo; Jessica Castro; Jesús Matés; Marlon Bravo; Marc Ribó; Maria Vilanova; Antoni Benito
Journal:  Molecules       Date:  2021-03-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.